PortfoliosLab logoPortfoliosLab logo
MEDP vs. INMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MEDP vs. INMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Medpace Holdings, Inc. (MEDP) and InMode Ltd. (INMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MEDP achieves a -20.66% return, which is significantly lower than INMD's -8.10% return.


MEDP

1D
-1.30%
1M
6.72%
YTD
-20.66%
6M
-23.66%
1Y
49.62%
3Y*
28.08%
5Y*
21.44%
10Y*

INMD

1D
-0.66%
1M
-6.32%
YTD
-8.10%
6M
-5.20%
1Y
-5.92%
3Y*
-26.14%
5Y*
-19.88%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MEDP vs. INMD - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
MEDP
Medpace Holdings, Inc.
-20.66%69.05%8.38%44.31%-2.40%56.35%65.60%5.98%
INMD
InMode Ltd.
-8.10%-12.04%-24.91%-37.70%-49.42%197.30%21.12%188.87%

Correlation

The correlation between MEDP and INMD is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.39

Correlation (3Y)
Calculated over the trailing 3-year period

0.36

Correlation (5Y)
Calculated over the trailing 5-year period

0.44

Correlation (All Time)
Calculated using the full available price history since Aug 9, 2019

0.41

Fundamentals

Market Cap

MEDP:

$12.91B

INMD:

$863.22M

EPS

MEDP:

$15.63

INMD:

$1.36

PE Ratio

MEDP:

28.50

INMD:

9.89

PS Ratio

MEDP:

4.90

INMD:

2.30

PB Ratio

MEDP:

21.57

INMD:

1.31

Total Revenue (TTM)

MEDP:

$2.68B

INMD:

$374.64M

Gross Profit (TTM)

MEDP:

$778.59M

INMD:

$291.61M

EBITDA (TTM)

MEDP:

$572.96M

INMD:

$98.61M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MEDP vs. INMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEDP
MEDP Risk / Return Rank: 6969
Overall Rank
MEDP Sharpe Ratio Rank: 6464
Sharpe Ratio Rank
MEDP Sortino Ratio Rank: 7070
Sortino Ratio Rank
MEDP Omega Ratio Rank: 7878
Omega Ratio Rank
MEDP Calmar Ratio Rank: 6767
Calmar Ratio Rank
MEDP Martin Ratio Rank: 6767
Martin Ratio Rank

INMD
INMD Risk / Return Rank: 2929
Overall Rank
INMD Sharpe Ratio Rank: 3333
Sharpe Ratio Rank
INMD Sortino Ratio Rank: 2929
Sortino Ratio Rank
INMD Omega Ratio Rank: 2929
Omega Ratio Rank
INMD Calmar Ratio Rank: 2929
Calmar Ratio Rank
INMD Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEDP vs. INMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and InMode Ltd. (INMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MEDPINMDDifference

Sharpe ratio

Return per unit of total volatility

0.72

-0.18

+0.90

Sortino ratio

Return per unit of downside risk

1.74

-0.03

+1.77

Omega ratio

Gain probability vs. loss probability

1.30

1.00

+0.30

Calmar ratio

Return relative to maximum drawdown

1.40

-0.34

+1.74

Martin ratio

Return relative to average drawdown

3.23

-0.72

+3.95

MEDP vs. INMD - Sharpe Ratio Comparison

The current MEDP Sharpe Ratio is 0.72, which is higher than the INMD Sharpe Ratio of -0.18. The chart below compares the historical Sharpe Ratios of MEDP and INMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MEDPINMDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.72

-0.18

+0.90

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.42

-0.38

+0.80

Sharpe Ratio (All Time)

Calculated using the full available price history

0.66

0.17

+0.48

Drawdowns

MEDP vs. INMD - Drawdown Comparison

The maximum MEDP drawdown since its inception was -42.87%, smaller than the maximum INMD drawdown of -86.96%. Use the drawdown chart below to compare losses from any high point for MEDP and INMD.


Loading charts...

Drawdown Indicators


MEDPINMDDifference

Max Drawdown

Largest peak-to-trough decline

-42.87%

-86.96%

+44.09%

Max Drawdown (1Y)

Largest decline over 1 year

-36.61%

-23.23%

-13.38%

Max Drawdown (3Y)

Largest decline over 3 years

-39.38%

-72.28%

+32.90%

Max Drawdown (5Y)

Largest decline over 5 years

-42.87%

-86.96%

+44.09%

Current Drawdown

Current decline from peak

-28.20%

-86.20%

+58.00%

Average Drawdown

Average peak-to-trough decline

-12.89%

-55.94%

+43.05%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.83%

11.00%

+4.83%

Volatility

MEDP vs. INMD - Volatility Comparison

The current volatility for Medpace Holdings, Inc. (MEDP) is 6.99%, while InMode Ltd. (INMD) has a volatility of 7.91%. This indicates that MEDP experiences smaller price fluctuations and is considered to be less risky than INMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MEDPINMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.99%

7.91%

-0.92%

Volatility (6M)

Calculated over the trailing 6-month period

38.11%

25.37%

+12.74%

Volatility (1Y)

Calculated over the trailing 1-year period

69.32%

33.40%

+35.92%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

51.61%

52.32%

-0.71%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

49.83%

60.98%

-11.15%

Dividends

MEDP vs. INMD - Dividend Comparison

Neither MEDP nor INMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

MEDP vs. INMD - Financials Comparison

This section allows you to compare key financial metrics between Medpace Holdings, Inc. and InMode Ltd.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M600.00M700.00M20222023202420252026
706.60M
82.02M
(MEDP) Total Revenue
(INMD) Total Revenue
Values in USD except per share items

MEDP vs. INMD - Profitability Comparison

The chart below illustrates the profitability comparison between Medpace Holdings, Inc. and InMode Ltd. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
27.8%
75.1%
Portfolio components
MEDP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a gross profit of 196.33M and revenue of 706.60M. Therefore, the gross margin over that period was 27.8%.

INMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported a gross profit of 61.55M and revenue of 82.02M. Therefore, the gross margin over that period was 75.1%.

MEDP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported an operating income of 141.50M and revenue of 706.60M, resulting in an operating margin of 20.0%.

INMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported an operating income of 10.06M and revenue of 82.02M, resulting in an operating margin of 12.3%.

MEDP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medpace Holdings, Inc. reported a net income of 123.87M and revenue of 706.60M, resulting in a net margin of 17.5%.

INMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, InMode Ltd. reported a net income of 11.56M and revenue of 82.02M, resulting in a net margin of 14.1%.


Frequently Asked Questions


MEDP and INMD have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INMD has higher volatility (7.91%) compared to MEDP (6.99%). In terms of maximum drawdown, MEDP dropped -42.87% vs INMD's -86.96%.

MEDP currently has the higher Sharpe Ratio (0.72 vs -0.18), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MEDP and INMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer